📊 BIOF Key Takeaways
Is Blue Biofuels, Inc.. (BIOF) a Good Investment?
Blue Biofuels exhibits severe financial distress with negative stockholders' equity of -$3.7M, indicating liabilities exceed assets by a significant margin. The company is unprofitable with a net loss of -$2.9M on minimal revenue of $60K, alongside negative operating cash flow of -$845K, demonstrating the business cannot sustain operations from core activities.
Fundamentals indicate severe financial distress: revenue is negligible relative to the cost structure, operating and net losses are extreme, and free cash flow remains deeply negative. The balance sheet is impaired by negative equity, very weak liquidity, and meaningful debt, which raises serious concerns about solvency and the sustainability of operations without external financing.
Why Buy Blue Biofuels, Inc.. Stock? BIOF Key Strengths
- Gross profit of $134.3K demonstrates underlying unit economics may be viable if scaled
- Relatively low absolute cash burn compared to potential debt obligations
- Minimal insider activity suggests no recent material concerns from management
- Positive gross profit suggests some underlying unit economics or non-core income support in the latest period
- Capital expenditure requirements are relatively modest, limiting near-term cash demands from investment spending
- The company maintains at least some reported revenue-generating activity rather than being entirely pre-revenue
BIOF Stock Risks: Blue Biofuels, Inc.. Investment Risks
- Negative stockholders' equity indicates company is technically insolvent and at risk of bankruptcy
- Operating cash flow is severely negative at -$845K with minimal revenue, indicating unsustainable burn rate
- Extreme leverage with $5.1M liabilities against $1.4M assets and only $65.2K cash creates imminent liquidity crisis
- Current ratio of 0.03x indicates severe inability to meet short-term obligations
- Diluted EPS of -$0.01 shows continued shareholder value destruction
- Current ratio of 0.03x and cash of $65.20K indicate acute liquidity stress
- Negative stockholders equity of $-3.71M and total liabilities of $5.11M reflect a highly impaired balance sheet
- Net loss of $-2.87M on just $60.00K of revenue shows an unsustainable operating model and weak growth quality
Key Metrics to Watch
- Cash balance and runway to insolvency
- Revenue growth trajectory and path to profitability
- Working capital management and ability to secure additional financing
- Operating cash flow trends for signs of operational improvement
- Quarterly revenue growth versus operating expense trend
- Cash burn and near-term financing/liquidity runway
Blue Biofuels, Inc.. (BIOF) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
BIOF Profit Margin, ROE & Profitability Analysis
BIOF vs Materials Sector: How Blue Biofuels, Inc.. Compares
How Blue Biofuels, Inc.. compares to Materials sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Blue Biofuels, Inc.. Stock Overvalued? BIOF Valuation Analysis 2026
Based on fundamental analysis, Blue Biofuels, Inc.. has mixed fundamental signals relative to the Materials sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Blue Biofuels, Inc.. Balance Sheet: BIOF Debt, Cash & Liquidity
BIOF Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Blue Biofuels, Inc..'s revenue has declined by 55% over the 5-year period, indicating business contraction. The most recent EPS of $-0.01 indicates the company is currently unprofitable.
BIOF Revenue Growth, EPS Growth & YoY Performance
Blue Biofuels, Inc.. Dividends, Buybacks & Capital Allocation
BIOF SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Blue Biofuels, Inc.. (CIK: 0001549145)
📋 Recent SEC Filings
❓ Frequently Asked Questions about BIOF
What is the AI rating for BIOF?
Blue Biofuels, Inc.. (BIOF) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 96% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are BIOF's key strengths?
Claude: Gross profit of $134.3K demonstrates underlying unit economics may be viable if scaled. Relatively low absolute cash burn compared to potential debt obligations. ChatGPT: Positive gross profit suggests some underlying unit economics or non-core income support in the latest period. Capital expenditure requirements are relatively modest, limiting near-term cash demands from investment spending.
What are the risks of investing in BIOF?
Claude: Negative stockholders' equity indicates company is technically insolvent and at risk of bankruptcy. Operating cash flow is severely negative at -$845K with minimal revenue, indicating unsustainable burn rate. ChatGPT: Current ratio of 0.03x and cash of $65.20K indicate acute liquidity stress. Negative stockholders equity of $-3.71M and total liabilities of $5.11M reflect a highly impaired balance sheet.
What is BIOF's revenue and growth?
Blue Biofuels, Inc.. reported revenue of $60.0K.
Does BIOF pay dividends?
Blue Biofuels, Inc.. does not currently pay dividends.
Where can I find BIOF SEC filings?
Official SEC filings for Blue Biofuels, Inc.. (CIK: 0001549145) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is BIOF's EPS?
Blue Biofuels, Inc.. has a diluted EPS of $-0.01.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is BIOF a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Blue Biofuels, Inc.. has a STRONG SELL rating with 96% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is BIOF stock overvalued or undervalued?
Valuation metrics for BIOF: ROE of N/A (sector avg: 14%), net margin of -4,791.0% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy BIOF stock in 2026?
Our dual AI analysis gives Blue Biofuels, Inc.. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is BIOF's free cash flow?
Blue Biofuels, Inc..'s operating cash flow is $-845.0K, with capital expenditures of $68.9K. FCF margin is -1,523.2%.
How does BIOF compare to other Materials stocks?
Vs Materials sector averages: Net margin -4,791.0% (avg: 10%), ROE N/A (avg: 14%), current ratio 0.03 (avg: 1.6).